Pharmaceutical Resources (PRX) Stock Price, Forecast & Analysis

NYSE:PRX

49.98
+0.02 (+0.04%)
At close: Sep 28, 2012
49.98
0 (0%)
After Hours: 9/28/2012, 4:27:09 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

PRX Key Statistics, Chart & Performance

Key Statistics
Market Cap1.79B
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares35.90M
FloatN/A
52 Week High52.33
52 Week Low25.74
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
PRX short term performance overview.The bars show the price performance of PRX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30

PRX long term performance overview.The bars show the price performance of PRX in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80

The current stock price of PRX is 49.98 null. In the past month the price increased by 0.42%. In the past year, price increased by 87.75%.

Pharmaceutical Resources / PRX Daily stock chart

PRX Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to PRX. When comparing the yearly performance of all stocks, PRX is one of the better performing stocks in the market, outperforming 95.63% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
PRX Full Technical Analysis Report

PRX Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A
PRX financials

PRX Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
PRX Analyst EstimatesPRX Analyst Ratings

PRX Ownership

Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
PRX Ownership

Pharmaceutical Resources / PRX FAQ

Can you provide the latest stock price for Pharmaceutical Resources?

The current stock price of PRX is 49.98 null. The price increased by 0.04% in the last trading session.


What is the dividend status of Pharmaceutical Resources?

PRX does not pay a dividend.


How is the ChartMill rating for Pharmaceutical Resources?

PRX has a ChartMill Technical rating of 9 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.


Is Pharmaceutical Resources (PRX) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PRX.